Exact Mass: 350.1994
Exact Mass Matches: 350.1994
Found 29 metabolites which its exact mass value is equals to given mass value 350.1994,
within given mass tolerance error 0.001 dalton. Try search metabolite list with more accurate mass tolerance error
0.0002 dalton.
Ethyl apovincaminate
3-Methyl-2-(3-pyridyl)-1-indoleoctanoic acid
Vinpocetine
Vinpocetine is an alkaloid. It has a role as a geroprotector. Vinpocetine has been investigated for the treatment of Epilepsy. N - Nervous system > N06 - Psychoanaleptics > N06B - Psychostimulants, agents used for adhd and nootropics C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C932 - Vinca Alkaloid Compound C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids C1907 - Drug, Natural Product D020011 - Protective Agents relative retention time with respect to 9-anthracene Carboxylic Acid is 0.895 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.892 Vinpocetine (Ethyl apovincaminate) is a derivative of the alkaloid Vincamine that blocks voltage-gated Na+ channels. The IC50 value of Vinpocetine on direct IKK inhibition in the cell-free system is 17.17 μM. Vinpocetine is a phosphodiesterase (PDE) inhibitor and inhibits NF-κB-dependent inflammatory responses by directly targeting IκB kinase complex (IKK), and has been widely used for the treatment of cerebrovascular disorders[1][2][3]. Vinpocetine (Ethyl apovincaminate) is a derivative of the alkaloid Vincamine that blocks voltage-gated Na+ channels. The IC50 value of Vinpocetine on direct IKK inhibition in the cell-free system is 17.17 μM. Vinpocetine is a phosphodiesterase (PDE) inhibitor and inhibits NF-κB-dependent inflammatory responses by directly targeting IκB kinase complex (IKK), and has been widely used for the treatment of cerebrovascular disorders[1][2][3].
Ethyl eburnamenine-14-carboxylate
D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000970 - Antineoplastic Agents > D014748 - Vinca Alkaloids D020011 - Protective Agents
19-methylene-ibogamine-18-carboxylic acid methyl ester|Coronaridin
16-acetoxy-3,15-dimethyl-17-nor-cura-2(16),19-diene
2-Pyrrolidinone, 4-(2-morpholinoethyl)-3,3-diphenyl-
2,5-dibenzyl-hexahydro-pyrrolo[3,4-c]pyrrole-3a-carboxylic acid methyl ester
3-Methyl-2-(3-pyridyl)-1-indoleoctanoic acid
D018501 - Antirheumatic Agents > D006074 - Gout Suppressants > D014528 - Uricosuric Agents D004791 - Enzyme Inhibitors
